SELLAS Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. 

CEO
Angelos M. Stergiou
CEOAngelos M. Stergiou
Employees
13
Employees13
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2006
Founded2006
Employees
13
Employees13

SLS Key Statistics

Market cap
2.79B
Market cap2.79B
Price-Earnings ratio
-65.59
Price-Earnings ratio-65.59
Dividend yield
Dividend yield
Average volume
15.51M
Average volume15.51M
High today
$15.05
High today$15.05
Low today
$12.95
Low today$12.95
Open price
$13.20
Open price$13.20
Volume
17.28M
Volume17.28M
52 Week high
$15.88
52 Week high$15.88
52 Week low
$1.39
52 Week low$1.39

Stock Snapshot

SELLAS Life Sciences(SLS) stock is priced at $14.81, giving the company a market capitalization of 2.79B. It carries a P/E multiple of -65.59.

On 2026-07-05, SELLAS Life Sciences(SLS) stock moved within a range of $12.95 to $15.05. With shares now at $14.81, the stock is trading +14.3% above its intraday low and -1.6% below the session's peak.

Trading volume for SELLAS Life Sciences(SLS) stock has reached 17.28M, versus its average volume of 15.51M.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

SLS News

TipRanks 3d
SELLAS Life Sciences Soars on Trial Hopes, Deal Buzz - TipRanks

...

SELLAS Life Sciences Soars on Trial Hopes, Deal Buzz - TipRanks
Simply Wall St 4d
Why SELLAS Life Sciences Group Is Up 62.7% After Phase 3 REGAL Trial Nears Final Data - And What's Next

In late June 2026, SELLAS Life Sciences Group drew heightened attention as its Phase 3 REGAL study in acute myeloid leukemia neared final analysis while recent...

Why SELLAS Life Sciences Group Is Up 62.7% After Phase 3 REGAL Trial Nears Final Data - And What's Next
Simply Wall St 7d
AI Infrastructure Stocks With Strong Earnings Growth and Healthy Balance Sheets

With global data sending mixed signals, from resilient Chinese manufacturing and shifting bond yields to uneven consumer confidence, many investors are looking...

AI Infrastructure Stocks With Strong Earnings Growth and Healthy Balance Sheets

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.